FR2396004B1 - - Google Patents

Info

Publication number
FR2396004B1
FR2396004B1 FR7819091A FR7819091A FR2396004B1 FR 2396004 B1 FR2396004 B1 FR 2396004B1 FR 7819091 A FR7819091 A FR 7819091A FR 7819091 A FR7819091 A FR 7819091A FR 2396004 B1 FR2396004 B1 FR 2396004B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7819091A
Other languages
French (fr)
Other versions
FR2396004A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of FR2396004A1 publication Critical patent/FR2396004A1/fr
Application granted granted Critical
Publication of FR2396004B1 publication Critical patent/FR2396004B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57Aryl or substituted aryl radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7819091A 1977-06-28 1978-06-27 Forme cristalline nouvelle de l'agent antiinflammatoire : acide 2-(4-chlorophenyl)-a-methyl-5-benzoxazolylacetique, procede pour sa preparation et application comme medicaments Granted FR2396004A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB26907/77A GB1590587A (en) 1977-06-28 1977-06-28 Benoxaprofen

Publications (2)

Publication Number Publication Date
FR2396004A1 FR2396004A1 (fr) 1979-01-26
FR2396004B1 true FR2396004B1 (enExample) 1981-09-18

Family

ID=10251100

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7819091A Granted FR2396004A1 (fr) 1977-06-28 1978-06-27 Forme cristalline nouvelle de l'agent antiinflammatoire : acide 2-(4-chlorophenyl)-a-methyl-5-benzoxazolylacetique, procede pour sa preparation et application comme medicaments

Country Status (17)

Country Link
EP (1) EP0000276B1 (enExample)
JP (1) JPS5411224A (enExample)
AT (1) AT360008B (enExample)
AU (1) AU518403B2 (enExample)
BE (1) BE868522A (enExample)
CH (1) CH631449A5 (enExample)
DE (2) DE2828074A1 (enExample)
DK (1) DK145419C (enExample)
FI (1) FI69453C (enExample)
FR (1) FR2396004A1 (enExample)
GB (1) GB1590587A (enExample)
IE (1) IE47009B1 (enExample)
IL (1) IL55015A (enExample)
IT (1) IT1105065B (enExample)
LU (1) LU79879A1 (enExample)
NZ (1) NZ187674A (enExample)
ZA (1) ZA783660B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
US3888864A (en) 1973-06-29 1975-06-10 Hoffmann La Roche Amino lower alkyl ether derivatives of opium alkaloids
GB1495488A (en) * 1976-06-23 1977-12-21 Ippco Int Pharma Patents Co Es Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids
IT1099589B (it) * 1978-08-04 1985-09-18 Ravizza Spa Processo per la preparazione di derivati dell'acido benzoxazolil propionico
IT1157295B (it) * 1982-07-19 1987-02-11 Ravizza Spa Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
WO2021116820A1 (en) * 2019-12-10 2021-06-17 Aurobindo Pharma Limited An improved process for the preparation of benoxaprofen
DE102022117931A1 (de) 2022-07-18 2024-01-18 HUECK System GmbH & Co. KG Profilanordnung mit wärmedämmung
US11981645B1 (en) 2023-10-10 2024-05-14 King Faisal University N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
GB1488003A (en) * 1973-10-23 1977-10-05 Lilly Industries Ltd 1,2-benzisoxazole derivatives processes for their preparation and their use as pharmaceuticals
US4087437A (en) * 1976-09-07 1978-05-02 Eli Lilly And Company 2-Phenyl-5-benzoxazolylalkanoic acid purification process

Also Published As

Publication number Publication date
NZ187674A (en) 1980-11-14
DE2862013D1 (en) 1982-10-28
EP0000276A1 (en) 1979-01-10
IL55015A0 (en) 1978-08-31
DK287578A (da) 1978-12-29
DE2828074A1 (de) 1979-01-11
DK145419B (da) 1982-11-15
CH631449A5 (fr) 1982-08-13
LU79879A1 (enExample) 1978-12-07
ATA466178A (de) 1980-05-15
AU3750178A (en) 1980-01-03
IT1105065B (it) 1985-10-28
IE47009B1 (en) 1983-11-30
FI69453B (fi) 1985-10-31
JPS6231714B2 (enExample) 1987-07-09
FI782043A7 (fi) 1978-12-29
BE868522A (fr) 1978-12-27
IL55015A (en) 1981-11-30
AT360008B (de) 1980-12-10
FR2396004A1 (fr) 1979-01-26
GB1590587A (en) 1981-06-03
AU518403B2 (en) 1981-10-01
FI69453C (fi) 1986-02-10
IE781277L (en) 1978-12-28
DK145419C (da) 1983-04-18
JPS5411224A (en) 1979-01-27
EP0000276B1 (en) 1982-09-01
IT7850048A0 (it) 1978-06-27
ZA783660B (en) 1979-06-27

Similar Documents

Publication Publication Date Title
FR2378402B1 (enExample)
FR2378294B2 (enExample)
AU495917B2 (enExample)
AR210643A1 (enExample)
AU71461S (enExample)
BE866391A (enExample)
BE851449A (enExample)
BE865722A (enExample)
BE868323A (enExample)
BE871419A (enExample)
BE871991A (enExample)
BE872973A (enExample)
BE873002A (enExample)
BG23438A1 (enExample)
BG23462A1 (enExample)
BG24331A1 (enExample)
BG24713A1 (enExample)
BG25808A1 (enExample)
BG25809A1 (enExample)
BG25810A1 (enExample)
BG25811A1 (enExample)
BG25812A1 (enExample)
BG25813A1 (enExample)
BG25815A1 (enExample)
BG25819A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse